We are live on ! Find out more
WEC

Winslow Evans & Crocker Portfolio holdings

AUM $528M
1-Year Est. Return 30.99%
This Fund
S&P 500
This Quarter Est. Return
+3.74%
1 Year Est. Return
+30.99%
3 Year Est. Return
+76.2%
5 Year Est. Return
+147.26%
10 Year Est. Return
AUM
$365M
AUM Growth
+$46.1M
Cap. Flow
+$37.6M
Cap. Flow %
10.3%
Top 10 Hldgs %
19.35%
Holding
1,326
New
84
Increased
304
Reduced
473
Closed
56

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$3.44M
2
ORCL icon
Oracle
ORCL
+$1.05M
3
ETP
Energy Transfer Partners L.p.
ETP
+$657K
4
HDB icon
HDFC Bank
HDB
+$522K
5
BA icon
Boeing
BA
+$473K

Sector Composition

Rank Sector Weight
1 Technology 19.43%
2 Healthcare 11.88%
3 Financials 10.98%
4 Consumer Discretionary 8.56%
5 Energy 7.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FLR icon
226
Fluor
FLR
$7.29B
$348K 0.1%
7,118
+6,400
+891% +$306K
CWB icon
227
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.64B
$347K 0.1%
6,999
+1,143
+20% +$56K
EFA icon
228
iShares MSCI EAFE ETF
EFA
$76.4B
$347K 0.1%
5,325
+709
+15% +$45.9K
KHC icon
229
Kraft Heinz
KHC
$30.4B
$347K 0.1%
4,053
-117
-3% -$10.6K
ACN icon
230
Accenture
ACN
$89.9B
$342K 0.09%
2,768
-210
-7% -$25.6K
TRGP icon
231
Targa Resources
TRGP
$60.4B
$339K 0.09%
6,850
-986
-13% -$49.6K
RDS.A
232
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$337K 0.09%
6,343
-1
-0% -$54
HON icon
233
Honeywell
HON
$77.1B
$336K 0.09%
2,794
+277
+11% +$32.7K
GSK icon
234
GSK
GSK
$103B
$334K 0.09%
6,202
-1
-0% -$53
TXN icon
235
Texas Instruments
TXN
$255B
$331K 0.09%
4,291
+323
+8% +$25.9K
APTV icon
236
Aptiv
APTV
$12B
$327K 0.09%
3,736
-86
-2% -$7.18K
AXP icon
237
American Express
AXP
$223B
$327K 0.09%
3,882
-2
-0.1% -$158
EPR icon
238
EPR Properties
EPR
$4.86B
$322K 0.09%
4,476
-432
-9% -$31.5K
ARI
239
Apollo Commercial Real Estate
ARI
$887M
$321K 0.09%
17,315
-1
-0% -$19
TGT icon
240
Target
TGT
$62.1B
$315K 0.09%
5,970
+1,040
+21% +$56.8K
FL
241
DELISTED
Foot Locker
FL
$315K 0.09%
6,385
+5,359
+522% +$348K
URI icon
242
United Rentals
URI
$71.1B
$312K 0.09%
2,764
+100
+4% +$11.2K
EFT
243
Eaton Vance Floating-Rate Income Trust
EFT
$283M
$312K 0.09%
20,595
-101
-0.5% -$1.53K
MDT icon
244
Medtronic
MDT
$107B
$311K 0.09%
3,508
-604
-15% -$50.9K
WCN
245
Waste Connections
WCN
$42.8B
$310K 0.09%
4,817
+4,646
+2,717% +$289K
TOTL icon
246
State Street DoubleLine Total Return Tactical ETF
TOTL
$4.11B
$308K 0.08%
6,260
-300
-5% -$14.8K
PEY icon
247
Invesco High Yield Equity Dividend Achievers ETF
PEY
$1.13B
$308K 0.08%
18,250
+1,850
+11% +$31.3K
DD icon
248
DuPont de Nemours
DD
$18.6B
$307K 0.08%
1,922
+225
+13% +$35.7K
DLR icon
249
Digital Realty Trust
DLR
$73.7B
$306K 0.08%
2,708
-2
-0.1% -$229
BLUE
250
DELISTED
bluebird bio
BLUE
$305K 0.08%
224

Similar funds

Winslow Evans & Crocker's Q2 2017 Portfolio in Review

As of Q2 2017, Winslow Evans & Crocker held 1,326 positions worth $365M, up 14% from $318M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Winslow Evans & Crocker deployed $37.6M of net new capital in Q2 2017, opening 84 new positions and adding to 304 existing holdings. Its largest new stake was Idexx Laboratories: 3,900 shares worth $629K.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Allergan plc, an estimated $3.44M trimmed.

  • Winslow Evans & Crocker's largest Q2 2017 buy was Idexx Laboratories: 3,900 shares worth $629K.
  • Winslow Evans & Crocker added most to Microsoft in Q2 2017, an estimated $3.28M increase.
  • Winslow Evans & Crocker's biggest Q2 2017 reduction was Allergan plc, cutting an estimated $3.44M.
  • Winslow Evans & Crocker fully exited State Street Energy Select Sector SPDR ETF in Q2 2017, selling an estimated $428K.
  • Winslow Evans & Crocker's ten largest holdings make up 19% of its $365M portfolio in Q2 2017.
  • Winslow Evans & Crocker opened 84 new positions and closed 56 in Q2 2017.
  • Winslow Evans & Crocker's portfolio value rose 14% quarter-over-quarter to $365M.

Based on Winslow Evans & Crocker's 13F filing for Q2 2017, filed 14 Jul 2017.